Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1980-10-07
1983-07-19
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
2604045, 26050117, 424 19, 424 35, 424362, A61K 906, A61K 31135, C07C 9300
Patent
active
043943900
ABSTRACT:
The invention relates to a novel method of administering propranolol, a known .beta.-adrenergic blocking agent widely used in the treatment of angina pectoris, arrhythmias, hypertension and other cardiac conditions, and migraine. The invention further relates to novel dosage forms of propranolol which are adapted for nasal administration and which include solutions, suspensions, gels and ointments.
REFERENCES:
patent: 4161530 (1979-07-01), Koella
patent: 4250163 (1981-02-01), Nagai
patent: 4284648 (1981-08-01), Hussain
Black, Brit. J. Pharmacol., vol. 25, 1965, pp. 577-591.
Stern, Arzmit. Forsch., vol. 24, 1974, pp. 70-71.
Martindale, The Extra Pharm., Pharm. Press. London, 26th Ed, 1972, pp. 1582-1583.
Bawarshi Rima
Hirai Shin-ichiro
Hussain Anwar A.
Fagelson Anna P.
University of Kentucky Research Foundation
LandOfFree
Nasal dosage forms of propranol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nasal dosage forms of propranol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nasal dosage forms of propranol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-751458